Dr. Zachery R. Reichert
Claim this profileUniversity of Michigan Comprehensive Cancer Center
Studies Prostate Cancer
Studies Cancer
10 reported clinical trials
23 drugs studied
Area of expertise
1Prostate Cancer
Stage IV
BRCA1 positive
BRCA1 negative
2Cancer
Affiliated Hospitals
Clinical Trials Zachery R. Reichert is currently running
Ruxolitinib + Enzalutamide
for Prostate Cancer
This phase I/II tests the safety, side effects and best dose of ruxolitinib in combination with enzalutamide and how well it works in treating patients with prostate cancer that remains despite blocking hormone production (castration-resistant) and that has spread from where it first started to other places in the body (metastatic). Ruxolitinib, a kinase inhibitor, slows down the growth of the tumor by blocking the proteins, JAK1 and JAK2, tumors use to grow. Enzalutamide, an androgen receptor inhibitor, works by blocking the effects of androgen (a male reproductive hormone). This may help stop the growth and spread of tumor cells that need testosterone to grow. Giving ruxolitinib in combination with enzalutamide may be safe, tolerable, and/or effective in treating metastatic castration-resistant prostate cancer.
Recruiting1 award Phase 1 & 24 criteria
ARX517 + Enzalutamide
for Prostate Cancer
This trial is testing ARX517, a new drug, in adults with advanced prostate cancer that doesn't respond to usual treatments. The study aims to see if the drug is safe and effective in stopping or slowing down cancer growth.
Recruiting1 award Phase 17 criteria
More about Zachery R. Reichert
Clinical Trial Related6 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Zachery R. Reichert has experience with
- Enzalutamide
- Ruxolitinib
- Abiraterone
- Androgen Deprivation Therapy (ADT)
- External Beam Radiotherapy
- Olaparib
Breakdown of trials Zachery R. Reichert has run
Prostate Cancer
Cancer
Metastatic Disease
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Zachery R. Reichert specialize in?
Zachery R. Reichert focuses on Prostate Cancer and Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are BRCA1 positive.
Is Zachery R. Reichert currently recruiting for clinical trials?
Yes, Zachery R. Reichert is currently recruiting for 2 clinical trials in Ann Arbor Michigan. If you're interested in participating, you should apply.
Are there any treatments that Zachery R. Reichert has studied deeply?
Yes, Zachery R. Reichert has studied treatments such as Enzalutamide, Ruxolitinib, Abiraterone.
What is the best way to schedule an appointment with Zachery R. Reichert?
Apply for one of the trials that Zachery R. Reichert is conducting.
What is the office address of Zachery R. Reichert?
The office of Zachery R. Reichert is located at: University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109 United States. This is the address for their practice at the University of Michigan Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.